drugset / Trial / NCT01055899
Safety Study of a Single Dose of REGN88(SAR153191)in Patients With Rheumatoid Arthritis
RandomizedSingle-groupQuadruple-blindTreatment
Summary
This study will test the safety and tolerability (how the body reacts to the drug) of REGN88 and placebo (an inactive substance that contains no medicine) in patients with Rheumatoid Arthritis.
Timeline
- Start
- 2008-07
- Primary completion
- 2009-03
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sarilumab | Monoclonal antibody | — | Subcutaneous |